Show simple item record

dc.contributor.authorShirjang, S
dc.contributor.authorMansoori, B
dc.contributor.authorSolali, S
dc.contributor.authorHagh, MF
dc.contributor.authorShamsasenjan, K
dc.date.accessioned2018-08-26T07:19:41Z
dc.date.available2018-08-26T07:19:41Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/45687
dc.description.abstractUnderstanding the role of toll-like receptors (TLRs)in the immunomodulation potential, differentiation, migration, and survival of mesenchymal stem cells (MSCs) is absolutely vital to fully exploiting their MSC-based therapeutic potential. Furthermore, through recognition of exogenous or endogenous ligands produced upon injury, TLRs have been linked to allograft rejection and maintenance of chronic inflammatory diseases, including Crohn's disease, rheumatoid arthritis. Characterizing the effect of TLRs in biological control of MSCs fate and function could improve our knowledge about the MSC-based cell therapy and immunotherapy. In this paper, we outline the impacts of TLR activation and mechanisms on MSCs immunomodulatory functions, differentiation, migration, and survivability. Moreover, we indicate that the expression patterns of TLRs in MSCs from different sources. (C) 2016 Published by Elsevier Inc.
dc.language.isoEnglish
dc.relation.ispartofCELLULAR IMMUNOLOGY
dc.subjectToll-like receptor
dc.subjectMesenchymal stem cell
dc.subjectMechanism
dc.subjectTherapeutic use
dc.subjectImmunology
dc.titleToll-like receptors as a key regulator of mesenchymal stem cell function: An up-to-date review
dc.typeReview
dc.citation.volume315
dc.citation.spage1
dc.citation.epage10
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.cellimm.2016.12.005


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record